DocGo Stock Surges 15%, Q4 Revenue Beats Expectations and Company Raises Guidance

LootboxPhobia · 2026-03-16T20:24:33+00:00

DocGo Inc. reported fourth-quarter revenue of $74.9 million, exceeding expectations, and despite losses surpassing analyst forecasts, the stock price rose 15%. The company raised its full-year fiscal 2026 revenue guidance to $290 million to $310 million, demonstrating confidence in business growth and improved cost efficiency.

LootboxPhobia

2026-03-16 20:24:33

Abstract generation in progress

New York - DocGo Inc. (NASDAQ:DCGO) reported fourth-quarter earnings that exceeded revenue expectations and raised the full-year outlook for fiscal 2026. Despite a larger-than-expected loss, the company’s improving financial trajectory drove the stock up 15%, and investors reacted positively.

The mobile healthcare and medical transportation provider reported fourth-quarter revenue of $74.9 million, surpassing analysts’ expectations of $70.35 million. However, this figure declined 38% from $120.8 million in the same period last year, primarily due to the gradual termination of immigration-related projects.

Excluding these projects, revenue grew 11% to $67.5 million. The company reported an adjusted loss per share of -$1.37, compared to an expected -$0.14. Net loss was $142.3 million, including $78 million in non-cash impairment charges.

DocGo raised its full-year revenue guidance for fiscal 2026 from the previous $280 million to $300 million, up to $290 million to $310 million. The midpoint of $300 million exceeded analysts’ consensus estimate of $291.4 million. The company also improved its adjusted EBITDA outlook to a loss of $5 million to $10 million, up from the previous guidance of a loss of $15 million to $25 million.

CEO Lee Bienstock stated, “The strong growth in our ‘Any Address Healthcare’ business supports our belief that DocGo’s services are well-positioned to meet the evolving needs of the healthcare landscape. We are raising our guidance based on record-breaking business volume so far in 2026 and the expected full-year impact of our cost-efficiency initiatives.”

The ‘Any Address Healthcare’ segment doubled in the fourth quarter, increasing from $4.3 million in the same period last year to $12.8 million. DocGo also announced that it has initiated formal procedures to explore strategic alternatives to maximize shareholder value.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes